2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$41.42+$0.87 (+2.13%)
Price as of Oct 02, 2026 4:10 PM EDT- $1.9BMarket Cap
- 137.55%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$41.42+$0.87 (+2.13%)
URGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.55 | ||
Change | -$0.08 (-0.20%) | ||
Open | $40.63 | ||
High | $41.26 | ||
Low | $40.10 | ||
Previous Close | $40.63 | ||
Volume | 624,624 | ||
30-Day Average Volume | 741,441 | ||
1-Week Change | -1.65% | ||
1-Month Change | -6.55% | ||
1-Year Change | 137.55% | ||
3-Year Change | 189.44% | ||
5-Year Change | 137.27% | ||
Fundamentals | |||
Shares Outstanding | 46.8M | ||
Total Assets | $252.6M | ||
Market Cap | $1.9B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $72.5M | ||
Net Income | -$14.4M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$8.7M | ||
EBITDA | -$8.6M | ||
Net Working Capital | $173.5M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -232 | ||
Enterprise Value/Revenue | 28 | ||
P/B | -14 | ||
P/E | -145 | ||
PEG | -4 | ||
Price/Free Cash Flow | -57 | ||
Price/Operating Cash Flow | -58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue